Marcus Dalton is an experienced patent professional with a robust background in the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Patents at CureVac since June 2021, Dalton previously held the position of Head of Patents at Stratagem IPM Ltd from November 2020 to June 2021. Dalton spent over two decades at GSK, where roles included Vice President Patents for the Vaccine division and Global Head of Patents for GSK Biologicals. Dalton managed a team of 20 patent attorneys across four jurisdictions worldwide and has a solid educational foundation from the University of Wales, Cardiff.
This person is not in any teams
This person is not in any offices